Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
Cancers|August 10, 2024
Analysis of Molecular Imaging and Laboratory Baseline Biomarkers in PSMA-RLT: Whole-Body Total Lesion PSMA (TLP) Predicts Overall SurvivalConnor Hein, Caroline Burgard, Arne Blickle, et al.
European Radiology|October 2, 2013
Diffusion-weighted imaging with acquisition of three b-values for response evaluation of neuroendocrine liver metastases undergoing selective internal radiotherapyGuido M Kukuk, Petra Mürtz, Frank Träber, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Automated PROMISE V2 Scoring from PSMA PET/CT Reports Using Large Language Models: A Comparative Evaluation of Prompt Design and Model PerformanceTilman Speicher, Isa Ethem Demirkol, Arne Blickle, et al.
European Radiology|June 9, 2016
Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapyFrederic Carsten Schmeel, Birgit Simon, Amir Sabet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 17, 2006
Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?Michael J Reinhardt, Kim Biermann, Michael Wissmeyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 16, 2012
Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre studyHojjat Ahmadzadehfar, Carsten Meyer, Samer Ezziddin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2010
Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapySamer Ezziddin, Martin Opitz, Mared Attassi, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 24, 2015
Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertensionLuca Donazzan, Felix Mahfoud, Sebastian Ewen, et al.
EJNMMI Research|July 6, 2025
Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopeniaMoritz B Bastian, Tilman Speicher, Arne Blickle, et al.
Clinical Nuclear Medicine|November 27, 2024
Outcome and Renal Safety of PSMA-Targeted Radioligand Therapy in mCRPC Patients With Preexisting Impaired Renal FunctionMoritz B Bastian, Maike Sieben, Caroline Burgard, et al.
Pageof 16